Search filters

List of works by Ellen Weisberg

Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies

scientific article published on 15 July 2019

Correction: Evaluation of ERK as a therapeutic target in acute myelogenous leukemia

scientific article published on 06 March 2020

Discovery of N-(4-(6-Acetamidopyrimidin-4-yloxy)phenyl)-2-(2-(trifluoromethyl)phenyl)acetamide (CHMFL-FLT3-335) as a Potent FMS-like Tyrosine Kinase 3 Internal Tandem Duplication (FLT3-ITD) Mutant Selective Inhibitor for Acute Myeloid Leukemia

scientific article published on 08 January 2019

Effects of the multi-kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia

scientific article published on 22 January 2020

Evaluation of ERK as a therapeutic target in acute myelogenous leukemia

scientific article published on 27 August 2019

Midostaurin, a Natural Product-Derived Kinase Inhibitor Recently Approved for the Treatment of Hematological MalignanciesPublished as part of the Biochemistry series "Biochemistry to Bedside".

scientific article

NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma

scientific article

Repurposing of Kinase Inhibitors for Treatment of COVID-19

scientific article published on 10 August 2020

The combination of FLT3 and SYK kinase inhibitors is toxic to leukaemia cells with CBL mutations

scientific article published on 14 January 2020

The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironment

scientific article

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.

scientific article published on 14 March 2010

Paulina is supported by:

About Paulina

Help